Douglas P. Baker - 05 Oct 2021 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: OPRX
Reported as of: 05 Oct 2021
Net transaction value: -$1,160,380
SEC form: 4
Accepted by SEC: 05 Oct 2021, 16:45:29 UTC
Prior SEC filing: 29 Sep 2021
Source filing: View source filing
Reporting owner signature: /s/ Douglas P. Baker

Key filing fact

Douglas P. Baker filed Form 4 for OptimizeRx Corp (OPRX) on 05 Oct 2021.

Key facts

This page summarizes Douglas P. Baker's Form 4 filing for OptimizeRx Corp (OPRX).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Oct 2021, 16:45.

Change

Previous filing in this sequence was filed on 29 Sep 2021.
Current net transaction value: -$1,160,380.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OPRX transaction

Common Stock (pursuant to 10B5-1 plan)

Sale

Transaction value: $336,880
Shares: -4,000
Change %: -10%
Price: $84.22^*
Shares after: 34,796
Date: 05 Oct 2021
Ownership: Direct
Footnotes: F2

OPRX transaction

Common Stock

Options Exercise

Transaction value: $75,100
Shares: +10,000
Change %: +29%
Price: $7.51
Shares after: 44,796
Date: 05 Oct 2021
Ownership: Direct

OPRX transaction

Common Stock (pursuant to 10B5-1 plan)

Sale

Transaction value: $823,500
Shares: -10,000
Change %: -22%
Price: $82.35^*
Shares after: 34,796
Date: 05 Oct 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OPRX transaction Derivative

Stock Option

Options Exercise

Transaction value: $75,100
Shares: -10,000
Change %: -22%
Price: $7.51
Shares after: 34,699
Date: 05 Oct 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $7.51

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Footnote F2

These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.